1349.HKHKSE
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
HK$2.26
ListedAug 13, 2002
SectorHealthcare
IndustryDrug Manufacturers — Specialty & Generic
CountryChina
Employees876
Websitehttps://www.fd-zj.com/DesktopModules/HT/chinese/home/Index.aspx
State-| CityShanghai| AddressZhangjiang Hi-Tech Park| Phone86 21 5895 3355
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of biopharmaceutical products in the People's Republic of China. It offers photodynamic technology drugs, such as aminolevulinic acid hydrochloride and hemoporfin for Injection; doxorubicin liposome under the Libord brand; genetic engineering drugs; and oral solid preparation technology drugs. The company was founded in 1996 and is based in Shanghai, the People's Republic of China.
Updated: Jun 17, 2026 00:39:34 EDT
More info on Yahoo Finance →

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
0.0
?
Div. Rate
HK$0.05
?
Div. Yield
2.26%
?
Payout Ratio
235.31%
?
Max Consec. Div. Years
11 years
?
Longest Consec. Div.
11 years
?
Div. Coverage
48%
?
Div. Stability Rate
0.37
?
Div. Growth Rate
50.00%
?
Score
69

Dividend History

Historical dividend payments by ex-dividend date.

Jul 10, 2025
HK$ 0.0321
Aug 26, 2024
HK$ 0.0217
Jul 4, 2024
HK$ 0.0757
Jun 5, 2023
HK$ 0.0798
Jul 5, 2022
HK$ 0.0859
Jun 1, 2021
HK$ 0.0579
Apr 2, 2020
HK$ 0.0775
Apr 30, 2019
HK$ 0.0818
Jun 13, 2018
HK$ 0.0371
Jun 15, 2017
HK$ 0.0560
May 19, 2016
HK$ 0.0358
Jun 4, 2015
HK$ 0.0623

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!